NCT06573944View on ClinicalTrials.gov

IUS Predicts Upadacitinib Efficacy in Patients With Moderate to Severe Crohn's Disease：a Prospective Study

RecruitingOBSERVATIONAL

Enrollment

34

Participants

Timeline

Start Date

January 16, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

September 30, 2025

Conditions

Crohn's DiseaseUpadacitinibIntestinal UltrasoundPredictors

Trial Locations (1)

410000

RECRUITING

The Third Xiangya Hospital of Central South University, Hunan

All Listed Sponsors

lead

The Third Xiangya Hospital of Central South University

OTHER